SENDOXAN Side Effects

5781727-6 | Fatigue, Pyrexia
on May 22, 2008 Male patient from UNITED STATES , 71 years of age, was diagnosed with chronic lymphocytic leukaemia and was treated with Sendoxan (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, pyrexia. Sendoxan dosage: . During the same period patient was treated with DOXORUBICIN HCL (1 Dosage Form = 2mg/ml Inj.) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), DELTISON (View Deltison Review and Deltison Label ), ONCOVIN (1 Dosage Form = 1mg/ml.) (View Oncovin Review and Oncovin Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized.

5352200-4 | Progressive Multifocal Leukoencephalopathy
Patient was taking Sendoxan (View Usage). Patient had the following side effects: progressive multifocal leukoencephalopathy on Jun 08, 2007 from FINLAND Additional patient health information: Female patient , 72 years of age, was diagnosed with burkitt's lymphoma and. Sendoxan dosage: . During the same period patient was treated with TREXAN (ORION) (View Trexan (orion) Review and Trexan (orion) Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), MABTHERA (View Mabthera Review and Mabthera Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ). Patient was hospitalized and became disabled.

5349713-8 | Progressive Multifocal Leukoencephalopathy
Adverse event was reported on May 31, 2007 by a Female patient taking Sendoxan (View Usage) (Dosage: ) was diagnosed with burkitt's lymphoma and. Location: UNITED STATES , 72 years of age, After Sendoxan was administered, patient had the following side effects: progressive multifocal leukoencephalopathy. During the same period patient was treated with TREXAN (ORION) (View Trexan (orion) Review and Trexan (orion) Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), MABTHERA (View Mabthera Review and Mabthera Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ). Patient was hospitalized and became disabled.

5349643-1 | Jc Virus Infection, Progressive Multifocal Leukoencephalopathy
on May 31, 2007 Male patient from UNITED STATES , 63 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Sendoxan (View Usage). Patient experienced the following unwanted or unexpected effects: jc virus infection, progressive multifocal leukoencephalopathy. Sendoxan dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), ONCOVIN (View Oncovin Review and Oncovin Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), ORAMET (View Oramet Review and Oramet Label ), EFFEXOR (View Effexor Review and Effexor Label ), DEPRAKINE DEPOT (View Deprakine Depot Review and Deprakine Depot Label ).


5334383-5 | Blood Pressure Decreased, Heart Rate Decreased, Hepatic Failure, Multi-organ Failure, Renal Failure
on May 04, 2007 Male patient from UNITED STATES , 44 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Sendoxan (View Usage). Patient had the following side effects: blood pressure decreased, heart rate decreased, hepatic failure, multi-organ failure, renal failure. Sendoxan dosage: . During the same period patient was treated with DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ).

5008256-1 | Bone Disorder, Breath Odour, Dysgeusia, Impaired Healing, Oral Pain, Osteonecrosis, Tooth Disorder, Tooth Extraction
Patient was taking Sendoxan (View Usage). After Sendoxan was administered, patient had the following side effects: bone disorder, breath odour, dysgeusia, impaired healing, oral pain, osteonecrosis (What is osteonecrosis?), tooth disorder (What is tooth disorder?), tooth extraction on May 11, 2006 from NORWAY Additional patient health information: Male patient , 59 years of age, was diagnosed with hypercalcaemia and. Sendoxan dosage: 400 Mg, Qw. During the same period patient was treated with PREDNISOLONE (15 Daily) (View Prednisolone Review and Prednisolone Label ), VELCADE (4 Doses Over 4 Weeks) (View Velcade Review and Velcade Label ), ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ).

5005696-1 | Bone Disorder, Breath Odour, Dysgeusia, Impaired Healing, Oral Pain, Tooth Disorder, Tooth Extraction
Adverse event was reported on May 11, 2006 by a Male patient taking Sendoxan (View Usage) (Dosage: 400 Mg, Qw) was diagnosed with hypercalcaemia and. Location: NORWAY , 59 years of age, Patient experienced the following unwanted or unexpected effects: bone disorder, breath odour, dysgeusia, impaired healing, oral pain, tooth disorder (What is tooth disorder?), tooth extraction. During the same period patient was treated with PREDNISOLONE (15 Daily) (View Prednisolone Review and Prednisolone Label ), VELCADE (4 Doses Over 4 Weeks) (View Velcade Review and Velcade Label ), ZOMETA (4 Mg, Qmo) (View Zometa Review and Zometa Label ).

4635106-5 | Agranulocytosis, Hepatic Enzyme Increased, Hepatitis B, Lung Disorder, Pleurisy, Pneumonia, Respiratory Tract Infection
on Apr 04, 2005 Female patient from , 65 years of age, was diagnosed with vasculitis (What is vasculitis?), polyneuropathy and was treated with Sendoxan (View Usage). Patient had the following side effects: agranulocytosis, hepatic enzyme increased, hepatitis b (What is hepatitis b?), lung disorder, pleurisy, pneumonia (What is pneumonia?), respiratory tract infection. Sendoxan dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), IMUREL (View Imurel Review and Imurel Label ). Patient was hospitalized.